{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:21:25Z","timestamp":1789986085591,"version":"4.0.1"},"publisher-location":"Cham","reference-count":133,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319226705","type":"print"},{"value":"9783319226712","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-22671-2_6","type":"book-chapter","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T17:03:54Z","timestamp":1449853434000},"page":"85-105","source":"Crossref","is-referenced-by-count":76,"title":["microRNAs and Neurodegenerative Diseases"],"prefix":"10.1007","author":[{"given":"Lifeng","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng King","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"2","key":"6_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"2","key":"6_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"7006","key":"6_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350\u20135.","journal-title":"Nature"},{"issue":"7027","key":"6_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769\u201373.","journal-title":"Nature"},{"issue":"7209","key":"6_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature07228","volume":"455","author":"M Selbach","year":"2008","unstructured":"Selbach M, et al. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455(7209):58\u201363.","journal-title":"Nature"},{"issue":"3","key":"6_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1261\/rna.783108","volume":"14","author":"M Bak","year":"2008","unstructured":"Bak M, et al. MicroRNA expression in the adult mouse central nervous system. RNA. 2008;14(3):432\u201344.","journal-title":"RNA"},{"issue":"7","key":"6_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf P, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401\u201314.","journal-title":"Cell"},{"issue":"17","key":"6_CR8","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1523\/JNEUROSCI.4815-07.2008","volume":"28","author":"TH Davis","year":"2008","unstructured":"Davis TH, et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci. 2008;28(17):4322\u201330.","journal-title":"J Neurosci"},{"issue":"5723","key":"6_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1126\/science.1109020","volume":"308","author":"AJ Giraldez","year":"2005","unstructured":"Giraldez AJ, et al. MicroRNAs regulate brain morphogenesis in zebrafish. Science. 2005;308(5723):833\u20138.","journal-title":"Science"},{"issue":"Pt 4","key":"6_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1242\/jcs.059659","volume":"123","author":"Y Kawase-Koga","year":"2010","unstructured":"Kawase-Koga Y, et al. RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci. 2010;123(Pt 4):586\u201394.","journal-title":"J Cell Sci"},{"issue":"12","key":"6_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrn2037","volume":"7","author":"KS Kosik","year":"2006","unstructured":"Kosik KS. The neuronal microRNA system. Nat Rev Neurosci. 2006;7(12):911\u201320.","journal-title":"Nat Rev Neurosci"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuroscience.2012.08.009","volume":"223","author":"HS McLoughlin","year":"2012","unstructured":"McLoughlin HS, et al. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 2012;223:285\u201395.","journal-title":"Neuroscience"},{"issue":"5842","key":"6_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1140481","volume":"317","author":"J Kim","year":"2007","unstructured":"Kim J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science. 2007;317(5842):1220\u20134.","journal-title":"Science"},{"issue":"29","key":"6_CR14","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.1073\/pnas.1006151107","volume":"107","author":"S Haramati","year":"2010","unstructured":"Haramati S, et al. miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A. 2010;107(29):13111\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"6_CR15","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","volume":"19","author":"SS Hebert","year":"2010","unstructured":"Hebert SS, et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet. 2010;19(20):3959\u201369.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"6_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77(1):43\u201351.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"6_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-2008-14103","volume":"14","author":"JP Cogswell","year":"2008","unstructured":"Cogswell JP, et al. Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14(1):27\u201341.","journal-title":"J Alzheimers Dis"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"894938","DOI":"10.4061\/2011\/894938","volume":"2011","author":"C Delay","year":"2011","unstructured":"Delay C, Hebert SS. MicroRNAs and Alzheimer\u2019s disease mouse models: current insights and future research avenues. Int J Alzheimers Dis. 2011;2011:894938.","journal-title":"Int J Alzheimers Dis"},{"issue":"17","key":"6_CR19","doi-asserted-by":"publisher","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, et al. Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci U S A. 2008;105(17):6415\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"6_CR20","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/gb-2013-14-7-r78","volume":"14","author":"P Leidinger","year":"2013","unstructured":"Leidinger P, et al. A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol. 2013;14(7):R78.","journal-title":"Genome Biol"},{"issue":"3","key":"6_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/WNR.0b013e3280148e8b","volume":"18","author":"WJ Lukiw","year":"2007","unstructured":"Lukiw WJ. Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport. 2007;18(3):297\u2013300.","journal-title":"Neuroreport"},{"issue":"4-5","key":"6_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.brainresbull.2009.08.006","volume":"80","author":"X Wang","year":"2009","unstructured":"Wang X, et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res Bull. 2009;80(4-5):268\u201373.","journal-title":"Brain Res Bull"},{"issue":"24","key":"6_CR23","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1212\/01.wnl.0000437306.37850.22","volume":"81","author":"C Sala Frigerio","year":"2013","unstructured":"Sala Frigerio C, et al. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology. 2013;81(24):2103\u20136.","journal-title":"Neurology"},{"issue":"2","key":"6_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008898","volume":"5","author":"J Nunez-Iglesias","year":"2010","unstructured":"Nunez-Iglesias J, et al. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer\u2019s disease cortex reveals altered miRNA regulation. PLoS One. 2010;5(2), e8898.","journal-title":"PLoS One"},{"issue":"2","key":"6_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neulet.2009.04.052","volume":"459","author":"P Sethi","year":"2009","unstructured":"Sethi P, Lukiw WJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer\u2019s disease temporal lobe neocortex. Neurosci Lett. 2009;459(2):100\u20134.","journal-title":"Neurosci Lett"},{"issue":"2","key":"6_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00401-010-0756-0","volume":"121","author":"WX Wang","year":"2011","unstructured":"Wang WX, et al. Patterns of microRNA expression in normal and early Alzheimer\u2019s disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2011;121(2):193\u2013205.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"6_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","volume":"28","author":"WX Wang","year":"2008","unstructured":"Wang WX, et al. The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008;28(5):1213\u201323.","journal-title":"J Neurosci"},{"issue":"12","key":"6_CR28","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/onc.2010.531","volume":"30","author":"Y Wang","year":"2011","unstructured":"Wang Y, et al. Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene. 2011;30(12):1470\u201380.","journal-title":"Oncogene"},{"issue":"6","key":"6_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011070","volume":"5","author":"N Schonrock","year":"2010","unstructured":"Schonrock N, et al. Neuronal microRNA deregulation in response to Alzheimer\u2019s disease amyloid-beta. PLoS One. 2010;5(6), e11070.","journal-title":"PLoS One"},{"issue":"3","key":"6_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","volume":"13","author":"R Yan","year":"2014","unstructured":"Yan R, Vassar R. Targeting the beta secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol. 2014;13(3):319\u201329.","journal-title":"Lancet Neurol"},{"issue":"2","key":"6_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1101\/gad.1975411","volume":"25","author":"AJ Kole","year":"2011","unstructured":"Kole AJ, et al. miR-29b is activated during neuronal maturation and targets BH3-only genes to restrict apoptosis. Genes Dev. 2011;25(2):125\u201330.","journal-title":"Genes Dev"},{"issue":"6","key":"6_CR32","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1460-9568.2005.03978.x","volume":"21","author":"L Smirnova","year":"2005","unstructured":"Smirnova L, et al. Regulation of miRNA expression during neural cell specification. Eur J Neurosci. 2005;21(6):1469\u201377.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"6_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.nbd.2008.11.009","volume":"33","author":"SS Hebert","year":"2009","unstructured":"Hebert SS, et al. MicroRNA regulation of Alzheimer\u2019s Amyloid precursor protein expression. Neurobiol Dis. 2009;33(3):422\u20138.","journal-title":"Neurobiol Dis"},{"key":"6_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/1471-2164-12-176","volume":"12","author":"KH Ling","year":"2011","unstructured":"Ling KH, et al. Deep sequencing analysis of the developing mouse brain reveals a novel microRNA. BMC Genomics. 2011;12:176.","journal-title":"BMC Genomics"},{"issue":"9","key":"6_CR35","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1101\/gr.106849.110","volume":"20","author":"M Somel","year":"2010","unstructured":"Somel M, et al. MicroRNA, mRNA, and protein expression link development and aging in human and macaque brain. Genome Res. 2010;20(9):1207\u201318.","journal-title":"Genome Res"},{"issue":"6","key":"6_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci. 2012;15(6):827\u201335.","journal-title":"Nat Neurosci"},{"issue":"7","key":"6_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1128\/MCB.01977-07","volume":"28","author":"I Ivanovska","year":"2008","unstructured":"Ivanovska I, et al. MicroRNAs in the miR-106b family regulate p21\/CDKN1A and promote cell cycle progression. Mol Cell Biol. 2008;28(7):2167\u201374.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"6_CR38","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1158\/0008-5472.CAN-06-4478","volume":"67","author":"S Landais","year":"2007","unstructured":"Landais S, et al. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res. 2007;67(12):5699\u2013707.","journal-title":"Cancer Res"},{"issue":"1","key":"6_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016138","volume":"6","author":"HI Trompeter","year":"2011","unstructured":"Trompeter HI, et al. MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One. 2011;6(1), e16138.","journal-title":"PLoS One"},{"issue":"16","key":"6_CR40","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2008-09-178707","volume":"113","author":"D Sampath","year":"2009","unstructured":"Sampath D, et al. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 2009;113(16):3744\u201353.","journal-title":"Blood"},{"issue":"1","key":"6_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/carcin\/bgs320","volume":"34","author":"G Shen","year":"2013","unstructured":"Shen G, et al. miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma. Carcinogenesis. 2013;34(1):211\u20139.","journal-title":"Carcinogenesis"},{"issue":"1","key":"6_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.celrep.2013.08.042","volume":"5","author":"P Nilsson","year":"2013","unstructured":"Nilsson P, et al. Abeta secretion and plaque formation depend on autophagy. Cell Rep. 2013;5(1):61\u20139.","journal-title":"Cell Rep"},{"issue":"4","key":"6_CR43","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1182\/blood-2011-02-336487","volume":"118","author":"A Meenhuis","year":"2011","unstructured":"Meenhuis A, et al. MiR-17\/20\/93\/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood. 2011;118(4):916\u201325.","journal-title":"Blood"},{"issue":"7","key":"6_CR44","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1172\/JCI29178","volume":"116","author":"JM Savitt","year":"2006","unstructured":"Savitt JM, Dawson VL, Dawson TM. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest. 2006;116(7):1744\u201354.","journal-title":"J Clin Invest"},{"issue":"6","key":"6_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S. Parkinson\u2019s disease: mechanisms and models. Neuron. 2003;39(6):889\u2013909.","journal-title":"Neuron"},{"issue":"5646","key":"6_CR46","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science. 2003;302(5646):819\u201322.","journal-title":"Science"},{"issue":"15","key":"6_CR47","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","volume":"20","author":"E Minones-Moyano","year":"2011","unstructured":"Minones-Moyano E, et al. MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function. Hum Mol Genet. 2011;20(15):3067\u201378.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"6_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025443","volume":"6","author":"M Martins","year":"2011","unstructured":"Martins M, et al. Convergence of miRNA expression profiling, alpha-synuclein interaction and GWAS in Parkinson\u2019s disease. PLoS One. 2011;6(10), e25443.","journal-title":"PLoS One"},{"issue":"1","key":"6_CR49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12031-009-9325-1","volume":"41","author":"S Asikainen","year":"2010","unstructured":"Asikainen S, et al. Global microRNA expression profiling of Caenorhabditis elegans Parkinson\u2019s disease models. J Mol Neurosci. 2010;41(1):210\u20138.","journal-title":"J Mol Neurosci"},{"issue":"10","key":"6_CR50","first-page":"855","volume":"9","author":"J Li","year":"2009","unstructured":"Li J, Dani JA, Le W. The role of transcription factor Pitx3 in dopamine neuron development and Parkinson\u2019s disease. Curr Top Med Chem. 2009;9(10):855\u20139.","journal-title":"Curr Top Med Chem"},{"issue":"2","key":"6_CR51","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2011.12.046","volume":"46","author":"MM Mouradian","year":"2012","unstructured":"Mouradian MM. MicroRNAs in Parkinson\u2019s disease. Neurobiol Dis. 2012;46(2):279\u201384.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"6_CR52","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/S1474-4422(08)70194-7","volume":"7","author":"JC van Swieten","year":"2008","unstructured":"van Swieten JC, Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 2008;7(10):965\u201374.","journal-title":"Lancet Neurol"},{"issue":"1","key":"6_CR53","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2353\/ajpath.2010.091202","volume":"177","author":"WX Wang","year":"2010","unstructured":"Wang WX, et al. miR-107 regulates granulin\/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol. 2010;177(1):334\u201345.","journal-title":"Am J Pathol"},{"issue":"2","key":"6_CR54","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s12032-011-9823-1","volume":"29","author":"L Feng","year":"2012","unstructured":"Feng L, et al. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol. 2012;29(2):856\u201363.","journal-title":"Med Oncol"},{"issue":"8","key":"6_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006677","volume":"4","author":"Y Takahashi","year":"2009","unstructured":"Takahashi Y, et al. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One. 2009;4(8), e6677.","journal-title":"PLoS One"},{"issue":"14","key":"6_CR56","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.1073\/pnas.0911082107","volume":"107","author":"M Yamakuchi","year":"2010","unstructured":"Yamakuchi M, et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A. 2010;107(14):6334\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"6_CR57","doi-asserted-by":"publisher","first-page":"13421","DOI":"10.1073\/pnas.0801613105","volume":"105","author":"M Yamakuchi","year":"2008","unstructured":"Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A. 2008;105(36):13421\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"6_CR58","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1134\/S0006297912080020","volume":"77","author":"EV Filatova","year":"2012","unstructured":"Filatova EV, et al. MicroRNAs: possible role in pathogenesis of Parkinson\u2019s disease. Biochemistry (Mosc). 2012;77(8):813\u20139.","journal-title":"Biochemistry (Mosc)"},{"issue":"5","key":"6_CR59","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/jid.2009.438","volume":"130","author":"D Antonini","year":"2010","unstructured":"Antonini D, et al. Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells. J Invest Dermatol. 2010;130(5):1249\u201357.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"6_CR60","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2007.05.010","volume":"26","author":"TC Chang","year":"2007","unstructured":"Chang TC, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007;26(5):745\u201352.","journal-title":"Mol Cell"},{"issue":"5","key":"6_CR61","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.233585.113","volume":"28","author":"N Okada","year":"2014","unstructured":"Okada N, et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 2014;28(5):438\u201350.","journal-title":"Genes Dev"},{"issue":"3","key":"6_CR62","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/hmg\/dds470","volume":"22","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, et al. MicroRNA-205 regulates the expression of Parkinson\u2019s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet. 2013;22(3):608\u201320.","journal-title":"Hum Mol Genet"},{"issue":"31","key":"6_CR63","doi-asserted-by":"publisher","first-page":"10820","DOI":"10.1073\/pnas.0800658105","volume":"105","author":"JN Savas","year":"2008","unstructured":"Savas JN, et al. Huntington\u2019s disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc Natl Acad Sci U S A. 2008;105(31):10820\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6_CR64","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1091\/mbc.E08-08-0796","volume":"20","author":"A Jagannath","year":"2009","unstructured":"Jagannath A, Wood MJ. Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2. Mol Biol Cell. 2009;20(1):521\u20139.","journal-title":"Mol Biol Cell"},{"issue":"12","key":"6_CR65","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ncb1334","volume":"7","author":"A Jakymiw","year":"2005","unstructured":"Jakymiw A, et al. Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol. 2005;7(12):1267\u201374.","journal-title":"Nat Cell Biol"},{"issue":"20","key":"6_CR66","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Marti","year":"2010","unstructured":"Marti E, et al. A myriad of miRNA variants in control and Huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010;38(20):7219\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6_CR67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, et al. Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet. 2003;35(1):76\u201383.","journal-title":"Nat Genet"},{"issue":"3","key":"6_CR68","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, et al. A microRNA-based gene dysregulation pathway in Huntington\u2019s disease. Neurobiol Dis. 2008;29(3):438\u201345.","journal-title":"Neurobiol Dis"},{"issue":"53","key":"6_CR69","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, et al. The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease. J Neurosci. 2008;28(53):14341\u20136.","journal-title":"J Neurosci"},{"issue":"7255","key":"6_CR70","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nature08139","volume":"460","author":"AS Yoo","year":"2009","unstructured":"Yoo AS, et al. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature. 2009;460(7255):642\u20136.","journal-title":"Nature"},{"issue":"4","key":"6_CR71","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1634\/stemcells.2005-0441","volume":"24","author":"AM Krichevsky","year":"2006","unstructured":"Krichevsky AM, et al. Specific microRNAs modulate embryonic stem cell-derived neurogenesis. Stem Cells. 2006;24(4):857\u201364.","journal-title":"Stem Cells"},{"issue":"1","key":"6_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054222","volume":"8","author":"A Jovicic","year":"2013","unstructured":"Jovicic A, et al. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington\u2019s disease-related mechanisms. PLoS One. 2013;8(1), e54222.","journal-title":"PLoS One"},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2199-11-95","volume":"11","author":"M Guidi","year":"2010","unstructured":"Guidi M, et al. Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol Biol. 2010;11:95.","journal-title":"BMC Mol Biol"},{"key":"6_CR74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-6606-7-46","volume":"7","author":"J Kocerha","year":"2014","unstructured":"Kocerha J, et al. microRNA-128a dysregulation in transgenic Huntington\u2019s disease monkeys. Mol Brain. 2014;7:46.","journal-title":"Mol Brain"},{"issue":"1","key":"6_CR75","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2010.10.012","volume":"227","author":"ST Lee","year":"2011","unstructured":"Lee ST, et al. Altered microRNA regulation in Huntington\u2019s disease models. Exp Neurol. 2011;227(1):172\u20139.","journal-title":"Exp Neurol"},{"issue":"2","key":"6_CR76","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/BJ20100024","volume":"428","author":"J Remenyi","year":"2010","unstructured":"Remenyi J, et al. Regulation of the miR-212\/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J. 2010;428(2):281\u201391.","journal-title":"Biochem J"},{"issue":"45","key":"6_CR77","doi-asserted-by":"publisher","first-page":"16426","DOI":"10.1073\/pnas.0508448102","volume":"102","author":"N Vo","year":"2005","unstructured":"Vo N, et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A. 2005;102(45):16426\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"6_CR78","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/nn2010","volume":"10","author":"ME Klein","year":"2007","unstructured":"Klein ME, et al. Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci. 2007;10(12):1513\u20134.","journal-title":"Nat Neurosci"},{"issue":"5870","key":"6_CR79","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","volume":"319","author":"J Sreedharan","year":"2008","unstructured":"Sreedharan J, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319(5870):1668\u201372.","journal-title":"Science"},{"issue":"24","key":"6_CR80","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1101\/gad.1262504","volume":"18","author":"J Han","year":"2004","unstructured":"Han J, et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004;18(24):3016\u201327.","journal-title":"Genes Dev"},{"issue":"9","key":"6_CR81","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1073\/pnas.1112427109","volume":"109","author":"Y Kawahara","year":"2012","unstructured":"Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A. 2012;109(9):3347\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6_CR82","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/j.1742-4658.2010.07643.x","volume":"277","author":"E Buratti","year":"2010","unstructured":"Buratti E, et al. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277(10):2268\u201381.","journal-title":"FEBS J"},{"issue":"1","key":"6_CR83","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbrc.2011.09.068","volume":"414","author":"JM Pare","year":"2011","unstructured":"Pare JM, Lopez-Orozco J, Hobman TC. MicroRNA-binding is required for recruitment of human Argonaute 2 to stress granules and P-bodies. Biochem Biophys Res Commun. 2011;414(1):259\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"6_CR84","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cell.2013.07.038","volume":"154","author":"M Ramaswami","year":"2013","unstructured":"Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell. 2013;154(4):727\u201336.","journal-title":"Cell"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1756-6606-6-26","volume":"6","author":"D Campos-Melo","year":"2013","unstructured":"Campos-Melo D, et al. Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain. 2013;6:26.","journal-title":"Mol Brain"},{"issue":"20","key":"6_CR86","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1093\/hmg\/ddt261","volume":"22","author":"ED Koval","year":"2013","unstructured":"Koval ED, et al. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet. 2013;22(20):4127\u201335.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"6_CR87","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1172\/JCI62636","volume":"122","author":"O Butovsky","year":"2012","unstructured":"Butovsky O, et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012;122(9):3063\u201387.","journal-title":"J Clin Invest"},{"issue":"5959","key":"6_CR88","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1126\/science.1181046","volume":"326","author":"AH Williams","year":"2009","unstructured":"Williams AH, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326(5959):1549\u201354.","journal-title":"Science"},{"issue":"1","key":"6_CR89","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2007.02.035","volume":"129","author":"MA Fox","year":"2007","unstructured":"Fox MA, et al. Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals. Cell. 2007;129(1):179\u201393.","journal-title":"Cell"},{"key":"6_CR90","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","volume":"30","author":"RM O\u2019Connell","year":"2012","unstructured":"O\u2019Connell RM, Rao DS, Baltimore D. microRNA regulation of inflammatory responses. Annu Rev Immunol. 2012;30:295\u2013312.","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"6_CR91","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.4049\/jimmunol.1000491","volume":"185","author":"P Wang","year":"2010","unstructured":"Wang P, et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol. 2010;185(10):6226\u201333.","journal-title":"J Immunol"},{"issue":"53","key":"6_CR92","doi-asserted-by":"publisher","first-page":"41328","DOI":"10.1074\/jbc.M110.146852","volume":"285","author":"F Louafi","year":"2010","unstructured":"Louafi F, Martinez-Nunez RT, Sanchez-Elsner T. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem. 2010;285(53):41328\u201336.","journal-title":"J Biol Chem"},{"issue":"7","key":"6_CR93","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1073\/pnas.0910667107","volume":"107","author":"D Rai","year":"2010","unstructured":"Rai D, et al. Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A. 2010;107(7):3111\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6_CR94","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1021\/cn500149w","volume":"5","author":"L Qiu","year":"2014","unstructured":"Qiu L, et al. Deciphering the function and regulation of microRNAs in Alzheimer\u2019s disease and Parkinson\u2019s disease. ACS Chem Neurosci. 2014;5(10):884\u201394.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"6_CR95","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1021\/mp100315q","volume":"8","author":"XQ Liu","year":"2011","unstructured":"Liu XQ, et al. Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles. Mol Pharm. 2011;8(1):250\u20139.","journal-title":"Mol Pharm"},{"issue":"14","key":"6_CR96","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-10-0655","volume":"70","author":"JF Wiggins","year":"2010","unstructured":"Wiggins JF, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010;70(14):5923\u201330.","journal-title":"Cancer Res"},{"issue":"16","key":"6_CR97","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, et al. RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci U S A. 2005;102(16):5820\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6_CR98","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.expneurol.2005.12.024","volume":"198","author":"MK Sapru","year":"2006","unstructured":"Sapru MK, et al. Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Exp Neurol. 2006;198(2):382\u201390.","journal-title":"Exp Neurol"},{"issue":"2","key":"6_CR99","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/nar\/gkh208","volume":"32","author":"VM Miller","year":"2004","unstructured":"Miller VM, et al. Targeting Alzheimer\u2019s disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res. 2004;32(2):661\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"6_CR100","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1074\/jbc.M609293200","volume":"282","author":"Z Xie","year":"2007","unstructured":"Xie Z, et al. RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation. J Biol Chem. 2007;282(7):4318\u201325.","journal-title":"J Biol Chem"},{"issue":"10","key":"6_CR101","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nn1531","volume":"8","author":"O Singer","year":"2005","unstructured":"Singer O, et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005;8(10):1343\u20139.","journal-title":"Nat Neurosci"},{"issue":"3","key":"6_CR102","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1261\/rna.5235104","volume":"10","author":"G Meister","year":"2004","unstructured":"Meister G, et al. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA. 2004;10(3):544\u201350.","journal-title":"RNA"},{"issue":"4","key":"6_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020098","volume":"2","author":"G Hutvagner","year":"2004","unstructured":"Hutvagner G, et al. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004;2(4), E98.","journal-title":"PLoS Biol"},{"issue":"3","key":"6_CR104","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.molcel.2008.10.013","volume":"32","author":"G Michlewski","year":"2008","unstructured":"Michlewski G, et al. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Mol Cell. 2008;32(3):383\u201393.","journal-title":"Mol Cell"},{"issue":"7068","key":"6_CR105","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt J, et al. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature. 2005;438(7068):685\u20139.","journal-title":"Nature"},{"issue":"2","key":"6_CR106","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1074\/jbc.M109.033407","volume":"285","author":"DE Kuhn","year":"2010","unstructured":"Kuhn DE, et al. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem. 2010;285(2):1529\u201343.","journal-title":"J Biol Chem"},{"issue":"5","key":"6_CR107","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A Care","year":"2007","unstructured":"Care A, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13(5):613\u20138.","journal-title":"Nat Med"},{"issue":"9","key":"6_CR108","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nmeth1079","volume":"4","author":"MS Ebert","year":"2007","unstructured":"Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods. 2007;4(9):721\u20136.","journal-title":"Nat Methods"},{"issue":"16","key":"6_CR109","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0960-894X(98)00366-7","volume":"8","author":"R Kumar","year":"1998","unstructured":"Kumar R, et al. The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2\u2032-thio-LNA. Bioorg Med Chem Lett. 1998;8(16):2219\u201322.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"6_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","volume":"8","author":"DA Braasch","year":"2001","unstructured":"Braasch DA, Corey DR. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol. 2001;8(1):1\u20137.","journal-title":"Chem Biol"},{"issue":"9","key":"6_CR111","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","volume":"30","author":"J Kurreck","year":"2002","unstructured":"Kurreck J, et al. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 2002;30(9):1911\u20138.","journal-title":"Nucleic Acids Res"},{"issue":"7189","key":"6_CR112","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nature06783","volume":"452","author":"J Elmen","year":"2008","unstructured":"Elmen J, et al. LNA-mediated microRNA silencing in non-human primates. Nature. 2008;452(7189):896\u20139.","journal-title":"Nature"},{"issue":"5962","key":"6_CR113","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford RE, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327(5962):198\u2013201.","journal-title":"Science"},{"issue":"6","key":"6_CR114","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.chembiol.2010.05.014","volume":"17","author":"Y Li","year":"2010","unstructured":"Li Y, He C, Jin P. Emergence of chemical biology approaches to the RNAi\/miRNA pathway. Chem Biol. 2010;17(6):584\u20139.","journal-title":"Chem Biol"},{"issue":"11","key":"6_CR115","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1073\/pnas.1014720108","volume":"108","author":"S Melo","year":"2011","unstructured":"Melo S, et al. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A. 2011;108(11):4394\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"6_CR116","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nbt.1481","volume":"26","author":"G Shan","year":"2008","unstructured":"Shan G, et al. A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol. 2008;26(8):933\u201340.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"6_CR117","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/cr.2008.287","volume":"18","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Zhang C, Xi Z. Enhancement of RNAi by a small molecule antibiotic enoxacin. Cell Res. 2008;18(10):1077\u20139.","journal-title":"Cell Res"},{"issue":"32","key":"6_CR118","doi-asserted-by":"publisher","first-page":"24707","DOI":"10.1074\/jbc.M109.062976","volume":"285","author":"K Watashi","year":"2010","unstructured":"Watashi K, et al. Identification of small molecules that suppress microRNA function and reverse tumorigenesis. J Biol Chem. 2010;285(32):24707\u201316.","journal-title":"J Biol Chem"},{"issue":"3","key":"6_CR119","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrg2006","volume":"8","author":"DH Kim","year":"2007","unstructured":"Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet. 2007;8(3):173\u201384.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"6_CR120","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"6_CR121","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654\u20139.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"6_CR122","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0169-409X(01)00198-3","volume":"52","author":"G Borchard","year":"2001","unstructured":"Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev. 2001;52(2):145\u201350.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"6_CR123","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/sj.gt.3301461","volume":"8","author":"LS Uyechi","year":"2001","unstructured":"Uyechi LS, et al. Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components. Gene Ther. 2001;8(11):828\u201336.","journal-title":"Gene Ther"},{"issue":"2","key":"6_CR124","doi-asserted-by":"publisher","first-page":"025020","DOI":"10.1088\/1748-6041\/4\/2\/025020","volume":"4","author":"D Jere","year":"2009","unstructured":"Jere D, et al. Bioreducible polymers for efficient gene and siRNA delivery. Biomed Mater. 2009;4(2):025020.","journal-title":"Biomed Mater"},{"issue":"7092","key":"6_CR125","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D, et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature. 2006;441(7092):537\u201341.","journal-title":"Nature"},{"issue":"1","key":"6_CR126","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/mt.2008.231","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, Martins I, Davidson BL. Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo. Mol Ther. 2009;17(1):169\u201375.","journal-title":"Mol Ther"},{"issue":"15","key":"6_CR127","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL, et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci U S A. 2008;105(15):5868\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6_CR128","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/mt.2008.273","volume":"17","author":"K Keck","year":"2009","unstructured":"Keck K, et al. Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency. Mol Ther. 2009;17(3):538\u201347.","journal-title":"Mol Ther"},{"issue":"4","key":"6_CR129","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ymthe.2006.05.015","volume":"14","author":"DS An","year":"2006","unstructured":"An DS, et al. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol Ther. 2006;14(4):494\u2013504.","journal-title":"Mol Ther"},{"issue":"7","key":"6_CR130","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1261\/rna.25706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, et al. Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity. RNA. 2006;12(7):1179\u201387.","journal-title":"RNA"},{"issue":"7","key":"6_CR131","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1073\/pnas.0308698100","volume":"101","author":"PC Scacheri","year":"2004","unstructured":"Scacheri PC, et al. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A. 2004;101(7):1892\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"6_CR132","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1261\/rna.1326809","volume":"15","author":"J Burchard","year":"2009","unstructured":"Burchard J, et al. MicroRNA-like off-target transcript regulation by siRNAs is species specific. RNA. 2009;15(2):308\u201315.","journal-title":"RNA"},{"issue":"7","key":"6_CR133","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1261\/rna.30706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, et al. Position-specific chemical modification of siRNAs reduces \u201coff-target\u201d transcript silencing. RNA. 2006;12(7):1197\u2013205.","journal-title":"RNA"}],"container-title":["Advances in Experimental Medicine and Biology","microRNA: Medical Evidence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-22671-2_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T19:10:51Z","timestamp":1748718651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-22671-2_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319226705","9783319226712"],"references-count":133,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-22671-2_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}